REG - Inspiration Health - Change of auditor

Inspiration HealthcareAnnouncement

Wed 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251126:nRSZ9737Ia&default-theme=true

RNS Number : 9737I  Inspiration Healthcare Group PLC  26 November 2025

 

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

 

Change of Auditor

 

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology
company, announces that following the conclusion of a tender process overseen
by the Company's Audit Committee, the Company has appointed Crowe U.K. LLP
("Crowe U.K.") as the Company's independent auditor with effect from 25
November 2025.

 

Crowe U.K. will conduct the audit of the Company's financial statements for
the financial period to 31 January 2026 and any proposal to re-appoint Crowe
U.K. as auditors of the Company will be subject to the approval of
shareholders at the 2026 Annual General Meeting.

 

BDO LLP, the Company's outgoing independent auditor, has confirmed that there
are no matters connected with their ceasing to hold office that need to be
brought to the attention of the members or creditors of the Company for the
purposes of section 519 of the Companies Act 2006.

 

Enquiries:

 

 Inspiration Healthcare Group plc                                                     Tel: +44 (0)330
                                                      175 0000
 Raffi Stepanian, Chief Executive Officer

 Alan Olby, Chief Financial Officer

 Panmure Liberum (Nominated Adviser & Broker)                                                                                                   Tel: +44 (0)20
                                                                                                                3100 2000
 Will Goode

 Emma Earl

 Mark Rogers

 Walbrook PR Ltd (Media & IR)      Tel: +44 (0)20 7933 8780 or inspirationhealthcare@walbrookpr.com
                                   (mailto:inspirationhealthcare@walbrookpr.com)
 Anna Dunphy                                          Mob: +44 (0) 7876 741 001
 Rachel Broad                                         Mob: +44 (0) 7747 515 393

 

 

About Inspiration Healthcare

 

Inspiration Healthcare (AIM: IHC) designs, manufactures and markets
pioneering medical technology. Based in the UK, the Company specialises in
neonatal intensive care medical devices, which are addressing a critical need
to help to save the lives and improve the outcomes of patients, starting with
the very first breaths of life.

 

The Company has a broad portfolio of its own products and complementary
distributed products, for use in neonatal intensive care designed to support
even the most premature babies throughout their hospital stay. Its own branded
products range from highly sophisticated capital equipment such as ventilators
for life support through to single-use disposables.

 

The Company sells its products directly to hospitals and healthcare providers
in the UK and Ireland, where it also distributes a range of advanced medical
technologies for infusion therapy.  In the rest of the world the Company has
an established network of distribution partners around the world giving access
to more than 75 countries.

 

The Company operates in the UK from its world-class Manufacturing and
Technology Centre in Croydon, South London and in the USA from its facility in
Melbourne, Florida.

 

Further information on Inspiration Healthcare can be found
at www.inspirationhealthcaregroup.com
(http://www.inspirationhealthcaregroup.com/)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  APPBLBDBLUDDGUU



            Copyright 2019 Regulatory News Service, all rights reserved